ArticleMolecular cancer2026

EZH2 is a key prognostic marker and therapeutic target in aggressive and proliferative hepatoblastoma.

Fatma Zohra Khoubai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.